Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Giger

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
American Journal of Clinical Pathology|September 1, 1993
Failure of the Vitek AutoMicrobic system to detect beta-lactam resistance in Aeromonas speciesK H Schadow, D K Giger, C C Sanders
Infection and Immunity|February 1, 1978
Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicansD K Giger, J E Domer, J T McQuitty
Surgery|January 1, 1988
Morphologic and nutritional responses to intestinal patching following intestinal resectionJ S Thompson, R J Harty, J A Saigh, et al.
Infection and Immunity|September 1, 1978
Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted miceD K Giger, J E Domer, S A Moser, et al.
Journal of Clinical Microbiology|May 1, 1982
Plesiomonas shigelloides overgrowth in the small intestineR G Penn, D K Giger, F C Knoop, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1983
Comparison of moxalactam and gentamicin in the treatment of complicated urinary tract infectionsR G Penn, L C Preheim, C C Sanders, et al.
Human Pathology|September 1, 1980
The changing spectrum of disease, etiology, and diagnosis of mucormycosisA M Marchevsky, E J Bottone, S A Geller, et al.
Experientia|October 15, 1987
A new semisynthetic ergot peptide alkaloid: DCN 203-922R K Giger, H R Loosli, M D Walkinshaw, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1982
Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infectionsL C Preheim, R G Penn, C C Sanders, et al.
HIV Medicine|February 10, 2009
Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapyU S Kristoffersen, K Kofoed, G Kronborg, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
American Journal of Clinical Pathology|September 1, 1993
Failure of the Vitek AutoMicrobic system to detect beta-lactam resistance in Aeromonas speciesK H Schadow, D K Giger, C C Sanders
Infection and Immunity|February 1, 1978
Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicansD K Giger, J E Domer, J T McQuitty
Surgery|January 1, 1988
Morphologic and nutritional responses to intestinal patching following intestinal resectionJ S Thompson, R J Harty, J A Saigh, et al.
Infection and Immunity|September 1, 1978
Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted miceD K Giger, J E Domer, S A Moser, et al.
Journal of Clinical Microbiology|May 1, 1982
Plesiomonas shigelloides overgrowth in the small intestineR G Penn, D K Giger, F C Knoop, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1983
Comparison of moxalactam and gentamicin in the treatment of complicated urinary tract infectionsR G Penn, L C Preheim, C C Sanders, et al.
Human Pathology|September 1, 1980
The changing spectrum of disease, etiology, and diagnosis of mucormycosisA M Marchevsky, E J Bottone, S A Geller, et al.
Experientia|October 15, 1987
A new semisynthetic ergot peptide alkaloid: DCN 203-922R K Giger, H R Loosli, M D Walkinshaw, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1982
Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infectionsL C Preheim, R G Penn, C C Sanders, et al.
HIV Medicine|February 10, 2009
Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapyU S Kristoffersen, K Kofoed, G Kronborg, et al.
Pageof 2